In this discussion, Dr. Alex Marson, a professor of medicine at UCSF, dives into the intricate relationship between the immune system and cancer. He emphasizes the everyday choices we make that can either mitigate or elevate our risk of developing cancer, some of which might surprise you but are indeed actionable.
One of the key highlights is immunotherapy, particularly the role of engineered T-cells in battling both childhood and adult cancers. Dr. Marson elaborates on CAR T-cell therapy, a method that empowers the immune system to identify and destroy cancer cells more effectively.
The conversation also touches on CRISPR technology, a cutting-edge tool that enables gene editing to potentially cure various diseases. This raises important ethical considerations regarding gene editing, particularly in embryos and children.
Dr. Marson provides insights into the biological landscape of current diseases and how AI is influencing medical research. Furthermore, the discussion explores factors that bolster immune system health, including diet, sleep, and genetic influences.
You can find more about Dr. Marson and his work on his lab’s website:
https://www.marsonlab.org
For his studies and publications, visit:
https://gladstone.org/people/alex-marson#publications
This episode is made richer with support from our sponsors. For those interested in enhancing their health, don’t forget to check AG1 at:
https://drinkag1.com/huberman
Explore BetterHelp’s mental health services at:
https://betterhelp.com/huberman
If you’re looking for better sleep, Helix Sleep can be found here:
https://helixsleep.com/huberman
For hydration solutions, check out LMNT at:
https://drinklmnt.com/huberman
And for functional health products, visit:
https://functionhealth.com/huberman
Stay connected with Huberman Lab through various platforms, including Instagram:
https://www.instagram.com/hubermanlab
X:
https://x.com/hubermanlab
This comprehensive discussion is aimed at anyone keen on comprehending cancer prevention and the molecular mechanisms of immunotherapy and gene therapy.
By Andrew Huberman